To diagnose congestive heart failure (CHF)

 

The StatusFirst CHF test device utilizes biotin coupled anti-NT-proBNP antibody/streptavidin solid-phase chromatographic immunoassay technology.  After a sample has been dispensed into the sample well, the StatusFirst CHF test device is placed in the LifeSign DXpress™ Reader.

The LifeSign DXpress Reader displays the NT-proBNP concentration 15 minutes after sample addition. The LifeSign DXpress Reader is programmed to convert the intensity of the test device band (as indicated by the "pBNP" line on the test device) into a concentration of NT-proBNP automatically by using lot specific calibration factors supplied via a data chip in each box. The NT-proBNP concentration in the sample correlates with the intensity of the test device band. In some cases the bands may be visible prior to being read by the LifeSign DXpress™ Reader; however, no interpretation should be made based on the degree of visibility of the bands.

The StatusFirst® CHF NT-proBNP test is a quantitative immunoassay that measures N-terminal pro-Brain natriuretic peptide (NT-proBNP)
  • Plasma Sample
  • Easy to use - three drops of specimen into test device
  • Quantitative results in 15 minutes in DXpress™ Reader
  • Measures a range of 20 to 5000 pg/mL
  • Analytical Sensitivity of 20 pg/mL

 
With its easy procedure and fast turnaround
time, the LifeSign CHF is perfect for:
  • Emergency Rooms
  • Main Hospital Laboratories who are short-staffed
  • Urgent Care Facilities
  • Critical Care Clinics
  • Occupational Safety
  • Oncology
 
Procedure
  

Dispense three (3) drops (120ul) of blood, serum, or plasma into the test well
Read Results in 15 minutes
A line next to the marker and a line on the control line indicates the marker concentration is above the cutoff.

 

 

  
Copyright © 2010
DTA